Literature DB >> 23932782

Risk factors for depression in the elderly inflammatory bowel disease population.

Millie D Long1, Michael D Kappelman2, Christopher F Martin3, Wenli Chen4, Kristen Anton5, Robert S Sandler3.   

Abstract

BACKGROUND AND AIMS: Little is known about depression in elderly individuals with inflammatory bowel diseases (IBD). We assessed the point prevalence of depression and determined associations with disease activity, quality of life, and medication adherence in elderly patients with IBD.
METHODS: We identified elderly (≥ 65 years) individuals within Crohn's and Colitis Foundation of America Partners, an online IBD cohort. Individuals completed the short geriatric depression scale (GDS). We used bivariate statistics to determine whether demographic or disease-related factors, disease activity, quality of life or medication adherence was associated with depression. We used logistic regression to estimate independent effects of depression on medication adherence.
RESULTS: A total of 359 elderly individuals with IBD completed the GDS. The mean age was 70.2 years (SD 4.7); mean disease duration was 25.6 years (SD 17.6), and 62.6% had Crohn's disease (CD). The point prevalence of depression was 22.6%. Lower education levels (p=0.001), higher corticosteroid use (<0.01) and lower exercise levels (<0.001) were associated with depression. For both CD and ulcerative colitis (UC), those with depression had increased disease activity (short Crohn's disease activity index 52.5 versus 29, p=0.005, and simple clinical colitis activity index 5 versus 2, p=0.003). Depressed patients had lower quality of life (short IBD questionnaire 4.6 versus 5.7, p<0.001). Depressed individuals had reduced medication adherence (adjusted OR 2.18; 95% CI 1.04-4.57).
CONCLUSIONS: Depression is common in this geriatric IBD cohort. Depression is independently associated with reduced medication adherence. Recognition and treatment of depression in elderly patients with IBD could improve outcomes.
© 2013.

Entities:  

Keywords:  Adherence; Crohn's disease; Depression; Inflammatory bowel disease; Ulcerative colitis

Mesh:

Substances:

Year:  2013        PMID: 23932782      PMCID: PMC4589203          DOI: 10.1016/j.crohns.2013.07.002

Source DB:  PubMed          Journal:  J Crohns Colitis        ISSN: 1873-9946            Impact factor:   9.071


  30 in total

1.  Risk factors for depression in later life; results of a prospective community based study (AMSTEL).

Authors:  R A Schoevers; A T Beekman; D J Deeg; M I Geerlings; C Jonker; W Van Tilburg
Journal:  J Affect Disord       Date:  2000-08       Impact factor: 4.839

2.  Depression and inflammatory bowel disease: findings from two nationally representative Canadian surveys.

Authors:  Esme Fuller-Thomson; Joanne Sulman
Journal:  Inflamm Bowel Dis       Date:  2006-08       Impact factor: 5.325

3.  Short versions of the geriatric depression scale: a study of their validity for the diagnosis of a major depressive episode according to ICD-10 and DSM-IV.

Authors:  O P Almeida; S A Almeida
Journal:  Int J Geriatr Psychiatry       Date:  1999-10       Impact factor: 3.485

4.  Depressive symptoms and inflammatory bowel disease in children and adolescents: a cross-sectional study.

Authors:  Eva Szigethy; Anna Levy-Warren; Sarah Whitton; Athos Bousvaros; Kimberlee Gauvreau; Alan M Leichtner; William R Beardslee
Journal:  J Pediatr Gastroenterol Nutr       Date:  2004-10       Impact factor: 2.839

5.  The Manitoba IBD Index: evidence for a new and simple indicator of IBD activity.

Authors:  Ian Clara; Lisa M Lix; John R Walker; Lesley A Graff; Norine Miller; Linda Rogala; Patricia Rawsthorne; Charles N Bernstein
Journal:  Am J Gastroenterol       Date:  2009-05-19       Impact factor: 10.864

6.  Impact of depressive mood on relapse in patients with inflammatory bowel disease: a prospective 18-month follow-up study.

Authors:  Christian Mittermaier; Clemens Dejaco; Thomas Waldhoer; Anna Oefferlbauer-Ernst; Wolfgang Miehsler; Markus Beier; Wolfgang Tillinger; Alfred Gangl; Gabriele Moser
Journal:  Psychosom Med       Date:  2004 Jan-Feb       Impact factor: 4.312

7.  Prevalence and correlates of undiagnosed depression among U.S. adults with diabetes: the Behavioral Risk Factor Surveillance System, 2006.

Authors:  Chaoyang Li; Earl S Ford; Guixiang Zhao; Indu B Ahluwalia; William S Pearson; Ali H Mokdad
Journal:  Diabetes Res Clin Pract       Date:  2008-12-25       Impact factor: 5.602

8.  Prevalence of depression among U.S. adults with diabetes: findings from the 2006 behavioral risk factor surveillance system.

Authors:  Chaoyang Li; Earl S Ford; Tara W Strine; Ali H Mokdad
Journal:  Diabetes Care       Date:  2007-10-12       Impact factor: 19.112

9.  Psychological disorder and severity of inflammatory bowel disease predict health-related quality of life in ulcerative colitis and Crohn's disease.

Authors:  Elspeth Guthrie; Judy Jackson; Jon Shaffer; David Thompson; Barbara Tomenson; Francis Creed
Journal:  Am J Gastroenterol       Date:  2002-08       Impact factor: 10.864

10.  Predictive validity of a medication adherence measure in an outpatient setting.

Authors:  Donald E Morisky; Alfonso Ang; Marie Krousel-Wood; Harry J Ward
Journal:  J Clin Hypertens (Greenwich)       Date:  2008-05       Impact factor: 2.885

View more
  15 in total

Review 1.  Inflammatory Bowel Disease in the Baby to Baby Boomer: Pediatric and Elderly Onset of IBD.

Authors:  Anita Afzali; Seymour Katz
Journal:  Curr Treat Options Gastroenterol       Date:  2018-09

2.  Psychiatric morbidity in inflammatory bowel disease: Time to screen all the patients.

Authors:  Devendra Desai
Journal:  Indian J Gastroenterol       Date:  2018-07

3.  Challenges in the Diagnosis and Management of Inflammatory Bowel Disease in the Elderly.

Authors:  Sasha Taleban
Journal:  Curr Treat Options Gastroenterol       Date:  2015-09

4.  Depression Is Associated With More Aggressive Inflammatory Bowel Disease.

Authors:  Bharati Kochar; Edward L Barnes; Millie D Long; Kelly C Cushing; Joseph Galanko; Christopher F Martin; Laura E Raffals; Robert S Sandler
Journal:  Am J Gastroenterol       Date:  2017-11-14       Impact factor: 10.864

Review 5.  Influence of environmental factors in the development of inflammatory bowel diseases.

Authors:  Evangelia Legaki; Maria Gazouli
Journal:  World J Gastrointest Pharmacol Ther       Date:  2016-02-06

6.  Perceptions of patients with inflammatory bowel diseases on biobanking.

Authors:  Millie D Long; R Jean Cadigan; Suzanne F Cook; Kaaren Haldeman; Kriste Kuczynski; Robert S Sandler; Christopher F Martin; Wenli Chen; Michael D Kappelman
Journal:  Inflamm Bowel Dis       Date:  2015-01       Impact factor: 5.325

7.  High Patient Activation Is Associated With Remission in Patients With Inflammatory Bowel Disease.

Authors:  Edward L Barnes; Millie D Long; Michael D Kappelman; Christopher F Martin; Robert S Sandler
Journal:  Inflamm Bowel Dis       Date:  2019-06-18       Impact factor: 5.325

Review 8.  Depressive symptoms in inflammatory bowel disease: an extraintestinal manifestation of inflammation?

Authors:  C D Moulton; P Pavlidis; C Norton; S Norton; C Pariante; B Hayee; N Powell
Journal:  Clin Exp Immunol       Date:  2019-03-11       Impact factor: 4.330

9.  Physical activity and quality of life of patients with inflammatory bowel disease.

Authors:  Bun Kim; Jisuk Chae; Eun Hye Kim; Hyuk In Yang; Jae Hee Cheon; Tae Il Kim; Won Ho Kim; Justin Y Jeon; Soo Jung Park
Journal:  Medicine (Baltimore)       Date:  2021-07-09       Impact factor: 1.817

10.  Achieving Synergy: Linking an Internet-Based Inflammatory Bowel Disease Cohort to a Community-Based Inception Cohort and Multicentered Cohort in Inflammatory Bowel Disease.

Authors:  Bharati Kochar; Molly Aldridge; Suzanne Follan Cook; Renee Bright; Meaghan Mallette; Heather Moniz; Samir A Shah; Neal S LeLeiko; Jason Shapiro; Bruce E Sands; Wenli Chen; Elizabeth Jaeger; Joseph Galanko; Millie D Long; Christopher F Martin; Robert S Sandler; Michael D Kappelman
Journal:  J Med Internet Res       Date:  2016-06-03       Impact factor: 5.428

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.